Population aging and the introduction of new therapies for late-stage disease will grow the mature Parkinson’s disease market
This report addresses the following questions:
- What will be the growth drivers of the Parkinson’s disease market? - Which are the current top brands of the Parkinson’s disease market, and which new leaders will emerge after Azilect’s US patent expiry in 2017? - What is the landscape of early- and late-stage drug development in Parkinson’s disease? - How are Parkinson’s disease patients managed across the different disease stages? - Which treatment challenges still remain to be addressed?
Our reports have been used by over 10K customers, including:
The global behavioral health software market is expected to reach USD 4.9 billion by 2026 from USD 2.0 billion in 2021, at a CAGR of 19.6% during the forecast period. The major factors driving the growth of behavioral health software are the increasing adoption of behavioral health software, availability of government funding, government initiatives...